Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Colorectal Neoplasms 18Carcinoma, Non-Small-Cell Lung 14Breast Neoplasms 14Lung Neoplasms 12Head and Neck Neoplasms 10Rectal Neoplasms 8Prostatic Neoplasms 7Mouth Neoplasms 5Glioblastoma 5Esophageal Neoplasms 5Colonic Neoplasms 5Central Nervous System Neoplasms 5Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Hypopharyngeal Neoplasms 4Gliosarcoma 4Carcinoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Ovarian Neoplasms 3Neuroblastoma 3Neoplasms 3Laryngeal Neoplasms 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Turcot syndrome 2Tongue Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2

Interventions

Thalidomide 1Etoposide 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Brainstem Glioma × Celecoxib × Clear all
NCT01756989 2014-05-08

ANGIOCOMB Antiangiogenic Therapy for Pediatric Patients With Diffuse Brain Stem and Thalamic Tumors

Helsinki University Central Hospital

Phase 2 Completed
50 enrolled
CNS

Brainstem Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡